This morning Favus Institutional Research downgraded Questcor Pharmaceuticals (NASDAQ: QCOR) from Buy to Sell. Analysts expressed concern about the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE